- Metastatik Kolorektal Kanserli Hastaların RAS Mutasyon Durumuna Göre Klinik ve Patolojik Özellikleri
Mehmet SEZEN et al, 2019, Uludağ Üniversitesi Tıp Fakültesi Dergisi CrossRef - Mutational profile of KRAS, NRAS, BRAF, PIK3CA, and AKT1 genes in colorectal cancer patients in a tertiary care hospital, Dhaka
Sharmin Chowdhury et al, 2022, Advances in Cancer Biology - Metastasis CrossRef - Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: Next-generation sequencing–based cohort study
Mayank Jauhri et al, 2017, Tumor Biology CrossRef - Significant association between Let-7-KRAS rs712 G > T polymorphism and cancer risk in the Chinese population: a meta-analysis
Xin-Ya Du et al, 2017, Oncotarget CrossRef - Phytochemicals from Allium tuberosum Rottler ex Spreng Show Potent Inhibitory Activity against B-Raf, EGFR, K-Ras, and PI3K of Non-Small Cell Lung Cancer Targets
Rajat Nath et al, 2022, Applied Sciences CrossRef - Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer
Jiao Yang et al, 2016, Tumor Biology CrossRef - Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta‐analysis
Mahmood Moosazadeh et al, 2019, European Journal of Cancer Care CrossRef - Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS
T. Yoshino et al, 2018, Annals of Oncology CrossRef - Clinicopathological Associations of K-RAS and N-RAS Mutations in Indonesian Colorectal Cancer Cohort
Michael Levi et al, 2018, Journal of Gastrointestinal Cancer CrossRef - METASTATİK KOLOREKTAL KANSERLİ HASTALARIN EGFR YA DA VEGF İNHİBİTÖRÜ KULLANIM DURUMLARINA GÖRE KLİNİK ÖZELLİKLERİNİN İNCELENMESİ
Metin Deniz Karakoç et al, 2023, Kocatepe Tıp Dergisi CrossRef